Personalized Treatment Outcomes in Idiopathic Granulomatous Mastitis: A Retrospective Study of Ninety-Two Patients

A structured and individualized treatment approach may contribute to favorable clinical outcomes in patients with IGM. Observed relapse patterns support the importance of risk-adapted management rather than a uniform therapeutic strategy. Given the retrospective design and limited subgroup sizes, these findings should be interpreted cautiously and considered hypothesis-generating. Prospective, multicenter studies are required to validate relapse-associated factors and optimize treatment strategies.